Blueprint Medicines Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT™ (avapritinib) for the treatment of adult patients with advanced systemic mastocytosis (Advanced SM)...

Blueprint Medicines Corporation today announced that the U.S. Food and ...

Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the virtual 2021 American Society of Clinical Oncology (ASCO®) Annual Meeting held June 4-8.

Labcorp’s oncology platform brings together the company’s ...

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced its intelligent solution CytoSiA for rapid yet affordable scanning and analyzing of liquid-based cytology slides and pap-smears.

It is a complete solution consisting of OptraSCAN's digital pathology scanner, ...

BurstIQ, the leading provider of blockchain-based data exchange solutions, announced today that the company has entered into a research collaboration agreement with The National Center for Advancing Translational Sciences (NCATS).

At the National Institutes of Health (NIH) to address the ...

CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, announced that its ordinary shares have been approved for trading on the Nasdaq.

Global Market®  under the Company's current ticker symbol "CLGN" and will begin trading at the open of market on June 4, 2021. At such time, ...

Vivera Pharmaceuticals, Inc. is pleased to announce the allowance of its dose-controlled drug delivery device patent for ZICOH®.

Designed to better facilitate patient-provider interactions and play a role in reducing prescription opioid abuse, the ZICOH® device and its software are designed to ...